Regeneron Book Value Per Share from 2010 to 2024

REGN Stock  USD 883.20  7.48  0.84%   
Regeneron Pharmaceuticals Book Value Per Share yearly trend continues to be very stable with very little volatility. Book Value Per Share is likely to grow to 255.59 this year. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Regeneron Pharmaceuticals according to its financial statements. View All Fundamentals
 
Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
243.42174321
Current Value
255.59
Quarterly Volatility
89.63385435
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regeneron Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regeneron main balance sheet or income statement drivers, such as Depreciation And Amortization of 442.1 M, Interest Expense of 76.7 M or Total Revenue of 13.8 B, as well as many exotic indicators such as Price To Sales Ratio of 6.79, Dividend Yield of 0.007 or PTB Ratio of 5.22. Regeneron financial statements analysis is a perfect complement when working with Regeneron Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Regeneron Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Regeneron Pharmaceuticals Technical models . Check out the analysis of Regeneron Pharmaceuticals Correlation against competitors.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.

Latest Regeneron Pharmaceuticals' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Regeneron Pharmaceuticals over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Regeneron Pharmaceuticals' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regeneron Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 242.47 X10 Years Trend
Slightly volatile
   Book Value Per Share   
       Timeline  

Regeneron Book Value Per Share Regression Statistics

Arithmetic Mean89.92
Geometric Mean42.01
Coefficient Of Variation99.68
Mean Deviation73.69
Median53.01
Standard Deviation89.63
Sample Variance8,034
Range255
R-Value0.94
Mean Square Error1,017
R-Squared0.88
Slope18.83
Total Sum of Squares112,479

Regeneron Book Value Per Share History

2024 255.59
2023 243.42
2022 211.62
2021 177.57
2020 102.47
2019 101.55
2018 76.28

Other Fundumenentals of Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Book Value Per Share component correlations

1.0-0.060.990.980.970.980.830.980.580.930.870.290.950.761.00.960.990.650.88-0.910.760.610.9-0.67
1.0-0.090.990.960.950.970.850.960.550.940.850.270.940.741.00.940.990.640.87-0.90.770.620.9-0.69
-0.06-0.090.0-0.010.02-0.090.03-0.08-0.040.01-0.26-0.12-0.15-0.26-0.090.160.03-0.26-0.13-0.190.10.16-0.04-0.15
0.990.990.00.960.950.970.870.950.530.950.820.190.90.690.990.960.990.590.86-0.930.780.630.91-0.7
0.980.96-0.010.960.990.990.710.980.620.850.870.320.950.760.970.970.960.660.92-0.950.660.50.91-0.56
0.970.950.020.950.990.970.710.990.680.840.890.340.960.820.960.980.960.690.88-0.940.670.540.87-0.57
0.980.97-0.090.970.990.970.750.980.610.850.890.270.930.790.980.960.960.630.94-0.940.630.460.94-0.53
0.830.850.030.870.710.710.750.720.280.940.540.130.70.440.840.750.870.40.59-0.710.810.690.72-0.79
0.980.96-0.080.950.980.990.980.720.730.840.910.290.960.840.970.960.960.670.9-0.920.660.540.88-0.55
0.580.55-0.040.530.620.680.610.280.730.410.680.240.670.740.560.620.560.510.56-0.570.320.390.43-0.23
0.930.940.010.950.850.840.850.940.840.410.70.180.830.570.940.860.950.520.69-0.790.90.790.79-0.85
0.870.85-0.260.820.870.890.890.540.910.680.70.280.90.920.860.850.820.640.81-0.770.530.470.75-0.41
0.290.27-0.120.190.320.340.270.130.290.240.180.280.420.350.260.230.250.320.25-0.170.250.120.18-0.04
0.950.94-0.150.90.950.960.930.70.960.670.830.90.420.850.940.90.920.810.81-0.830.690.570.78-0.57
0.760.74-0.260.690.760.820.790.440.840.740.570.920.350.850.750.750.710.660.72-0.670.420.370.62-0.29
1.01.0-0.090.990.970.960.980.840.970.560.940.860.260.940.750.950.990.640.87-0.90.770.620.9-0.68
0.960.940.160.960.970.980.960.750.960.620.860.850.230.90.750.950.970.590.86-0.970.70.580.88-0.61
0.990.990.030.990.960.960.960.870.960.560.950.820.250.920.710.990.970.620.84-0.930.780.650.89-0.71
0.650.64-0.260.590.660.690.630.40.670.510.520.640.320.810.660.640.590.620.52-0.50.470.370.46-0.34
0.880.87-0.130.860.920.880.940.590.90.560.690.810.250.810.720.870.860.840.52-0.910.480.210.97-0.26
-0.91-0.9-0.19-0.93-0.95-0.94-0.94-0.71-0.92-0.57-0.79-0.77-0.17-0.83-0.67-0.9-0.97-0.93-0.5-0.91-0.58-0.41-0.930.48
0.760.770.10.780.660.670.630.810.660.320.90.530.250.690.420.770.70.780.470.48-0.580.890.58-0.81
0.610.620.160.630.50.540.460.690.540.390.790.470.120.570.370.620.580.650.370.21-0.410.890.31-0.9
0.90.9-0.040.910.910.870.940.720.880.430.790.750.180.780.620.90.880.890.460.97-0.930.580.31-0.4
-0.67-0.69-0.15-0.7-0.56-0.57-0.53-0.79-0.55-0.23-0.85-0.41-0.04-0.57-0.29-0.68-0.61-0.71-0.34-0.260.48-0.81-0.9-0.4
Click cells to compare fundamentals

About Regeneron Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Regeneron Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Regeneron Pharmaceuticals investors use historical funamental indicators, such as Regeneron Pharmaceuticals's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Regeneron Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Regeneron Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Regeneron Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Regeneron Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Regeneron Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Book Value Per Share 243.42  255.59 
Tangible Book Value Per Share 233.69  245.37 

Currently Active Assets on Macroaxis

When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out the analysis of Regeneron Pharmaceuticals Correlation against competitors.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Earnings Share
34.8
Revenue Per Share
122.935
Quarterly Revenue Growth
0.006
Return On Assets
0.0849
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.